12 Analysts Have This To Say About Ionis Pharmaceuticals
12 Analysts Have This To Say About Ionis Pharmaceuticals
有12名分析师就Ionis Pharmaceuticals发表了看法。
The standing of Ionis...Ionis Pharmaceuticals (NASDAQ:IONS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Ionis Pharmaceuticals(NASDAQ:IONS)在过去的三个月里被12位分析师进行了分析，得出了从看好到看淡的不同看法。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts have recently evaluated Ionis Pharmaceuticals and provided 12-month price targets. The average target is $63.83, accompanied by a high estimate of $82.00 and a low estimate of $53.00. Marking an increase of 8.04%, the current average surpasses the previous average price target of $59.08.
分析师们最近对Ionis Pharmaceuticals进行了评估，并提供了12个月的价值目标。平均目标为63.83美元，伴随着82.00美元的高估值和53.00美元的低估值。相较之前的平均目标价格59.08元，目前的平均值提高了8.04%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The standing of Ionis...
通过对最...
登录免费看全文
登录/注册